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Abstract
Erythema annulare centrifugum (EAC) is an unusual skin condition appearing as recurrent
erythematous annular eruptions associated with autoimmune disorders, infections, and various
neoplastic conditions. We present a very rarely reported association of EAC with Hashimoto
thyroiditis (HT) in a young male. A 26-year-old male recently diagnosed as case of HT
presented in the dermatology clinic with nine-month history of non-itchy persistent annular
lesions on the body. The morphology and biopsy of lesions confirmed the diagnosis of EAC.
HT is a part of the spectrum of autoimmune thyroid diseases with its own specific cutaneous
manifestations. Our case also depicts the impact of antigen-antibody related immunological
reaction, which might be involved in the development of both HT and EAC, and it could be the
stages of the same pathological condition of two different clinical presentations.
Categories: Dermatology, Endocrinology/Diabetes/Metabolism
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Introduction
Erythema annulare centrifugum (EAC) is an unusual skin condition that appears as recurrent
erythematous eruptions in the form of small and large annular plaques [1]. It is associated with
various autoimmune disorders, infections, and few neoplastic conditions. However, in most of
the cases, the exact cause is not clearly identified. The disease is classified into deep and
superficial types, but these types are not specifically associated with any systemic condition [2].
The term erythema annulare centrifugum was first described by Darier in 1916 [3]. Along with
usually described associations of EAC, literature has reported various unusual associations of
EAC, such as chronic active hepatitis, polyglandular syndrome, alopecia areata, and vitiligo [4].
Hashimoto thyroiditis (HT) is part of the spectrum of autoimmune thyroid diseases with its
own specific cutaneous manifestations [5]. In HT, thyroid cells are destroyed by the various
antibody-mediated immune processes. It is highly associated with other autoimmune diseases,
including type 1 diabetes mellitus, coeliac disease, adrenal insufficiency, and pernicious anemia
[6]. We report an interesting case of EAC associated with HT that presented as lesions of
figurate erythema over the body. HT is associated with various skin conditions, but the
association with EAC is very rarely reported previously.
Case Presentation
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A 26-year-old male was referred to skin clinic with nine-month history of non-itchy persistent
rashes over the body. They initially begin as small, raised papules and enlarged by peripheral
extension to form annular lesions. After a variable time period of weeks and months, the
individual lesions used to disappear, often to be replaced by new ones. It first appeared on his
nose as small pink raised papule, which slowly enlarged and formed rings and gradually spread
to his trunk and extremities. The lesions were asymptomatic, but they were cosmetically
disturbing to the patient. He was recently diagnosed as a case of HT and referred from
endocrinology clinic for his skin rash. There was no history of fever, weight loss, and insect
bite, traveling or taking any new drug except oral thyroxin. Local examination revealed annular
erythematous papules having raised infiltrated edges with central flattening and the fading of
erythema (Figure 1).
FIGURE 1: Annular erythematous plaque with central clearance
The margins were indurated, varying in width from 6 to 8 mm. Some lesions were extending
irregularly to leave arciform segments. They were present on the chest, back, buttocks and legs
with sparing of palms and soles. The polycyclic lesions varied from 10 to 20 cm (Figures 2, 3).
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FIGURE 2: Figurate erythema with well-defined indurated
borders on the back
FIGURE 3: Figurate erythema with well-defined indurated
borders on the chest
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The skin was generally dry. Systemic review revealed no abnormality. Hemogram, liver function
tests, Venereal Disease Research Laboratory test (VDRL), kidney function tests, and chest x ray
were normal. Potassium hydroxide (KOH) skin preparation was done to exclude the presence of
fungal hyphae. The diagnosis was then confirmed by the skin biopsy, which revealed ‘sleeve-
like’ lymphohistiocytic infiltrate in the middle and lower dermis (Figures 4, 5).
FIGURE 4: Perivascular lymphocytes in coat sleeve pattern
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FIGURE 5: Mild hyperkeratosis, flattened rete pegs. Dermis
exhibits tight perivascular inflammatory infiltrate
Topical steroids were used for the treatment of inflammatory lesions, and he was advised to
come for follow-ups to monitor the progress of disease.
Discussion
The descriptive term erythema annulare centrifugum comprises of redness (erythema), ring
form appearance (annulare), and spread from center (centrifugum) [7]. The age of occurrence
for EAC is variable, and it has been reported from infancy to ninth decade of life [1].
EAC is actually a skin hypersensitivity reaction to various underlying disorders like several type
of fungal, bacterial, and viral infections, different malignancies, and various drugs like lactone,
gold, cimetidine, lactone, antimalarials, and amitriptyline [8,9]. It is also reported to be
associated with some disorders like Graves’ disease, sarcoidosis, Crohn's disease, chronic active
hepatitis, and very rarely with hypothyroidism [10,11]. It is usually a self-limiting condition and
resolves with treatment of underlying disease. Hence, a search for the underlying disorder and
its treatment is the primary therapy [7].
HT is an autoimmune disease, and the initiating process is still not well understood. Antibodies
usually bind thyroid-stimulating hormone receptors, and thyrotrophic receptor blocking
antibodies may also contribute to impairment in thyroid function that results in inadequate
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thyroid hormone production and secretion [5,6]. It is most frequently associated with other
autoimmune conditions like type 1 diabetes mellitus, coeliac disease, pernicious anemia, and
adrenal insufficiency. Cutaneous manifestations of HT are decrease sweating, dryness of skin,
and diffuse hair loss [12].
The current case report highlights an interesting clinical association of HT with the unusual
skin lesions of EAC. In our patient, cutaneous findings appeared three months before the
clinical diagnosis of HT. The EAC is mainly characterized by superficial and deep type of
lesions. The deep type is clinically presented as an annular non-itchy and non-scaly indurated
plaque [8], where histopathology shows a dense perivascular infiltrate in the middle and lower
dermis [13], and the superficial form clinically presents as well-demarcated ring-like scaly
plaques [1-4]. Our patient had the deep type of EAC having a characteristic feature of non-scaly
well-demarcated indurated plaques.
As discussed above, the EAC is associated with different disorders and considered as a delayed
type of hypersensitivity reaction that is usually triggered by different antigens [12]. However,
the exact etiology for its appearance in autoimmune diseases is still unclear. One hypothesis is
that the T lymphocytes recognize antigen-presenting cells on surface receptors of thyroid cells
by autologous HLA molecules [14]. An interaction between the HLA molecule and antigenic
peptide is necessary. The literature supported this hypothesis by the appearance of parallel
course of autoimmune diseases and annular skin lesions in many cases [15]. However, there is
no published data where the autoimmune mechanism and association have been clearly
identified. Various genetic factors usually influence the effect of helper T-cell recognition and
autoantigen presentation [16]. The current case also depicts the impact of antigen-antibody
related immunological reaction, which might be involved in the development of both HT and
EAC, and it could be the stages of a same pathological condition of two different clinical
presentations [1].
The rare association of EAC with HT needs to be reported as the underlying immunologic
process of primary disease can affect any system, including the skin. Therefore, the disease
activity of HT would show rapid progression of skin problem that can also have rapid
improvement with treatment of underlying disease.
Conclusions
EAC is rarely associated with HT. Familiarity with this association would prompt physicians to
properly examine and then investigate for HT if required. EAC is a very rare condition, the
documentation of cases and information are sparse, and the current observations showed that
EAC could actually be a set of many unclassified skin lesions.
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